All lobbying filings

RK STRATEGIES, INC.

Lobbying for CLEARMIND MEDICINE, INC · Developer of Psychedelics Medicines

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · British Columbia · House · Senate · $10,000.00 income · posted Oct 20, 2025

Official filing document

Bills named in this filing 2

HR 2623
Innovative Therapies Centers of Excellence Act of 2025
HR 3838
Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 20…

Lobbying activity 4

Health Issues

Psychedelic Legislation H.R.2623, Innovative Therapies Centers of Excellence Act of 2025

Defense

Psychedelic Legislation H.R.2623, Innovative Therapies Centers of Excellence Act of 2025 H.R. 3838, the Streamlining Procurement for Effective Execution and Delivery Act

Alcohol and Drug Abuse

H.R. 3838, the Streamlining Procurement for Effective Execution and Delivery (SPEED) Act H.R.2623, Innovative Therapies Centers of Excellence Act of 2025 Issues Related to Psychedelic Medicines

Veterans

H.R.2623, Innovative Therapies Centers of Excellence Act of 2025

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.